Search
for
Sort by
Research 271–300 of 474
- Immunoglobulin E and Serum Interleukin-13 and Bacteria in Patients with Alopecia Areata
- Signaling pathways in hair aging
- Skin aging: mechanisms, evaluation, and rejuvenation
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Association between genetically predicted rheumatoid arthritis and alopecia areata: a two-sample Mendelian randomization study
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- New therapies for alopecia areata
- Pharmacological Treatment of Alopecia
- Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report
- Treatment Outcomes of Triamcinolone Acetonide Compared with Cryotherapy in Alopecia Areata: Evidence from a Systematic Review and Meta-Analysis
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Gut Microbiota and Autoimmune Alopecia Areata: Current Insights from the Literature
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- New treatment modalities of alopecia areata
- RETRACTED: Causal role of immune cells in alopecia areata: A two‐sample Mendelian randomization study
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Effects of biomaterials derived from germinated hemp seeds for stressed hair stem cells and immune cells
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata